Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM151B | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-08 |
mRNA | ZNF493 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | ZCCHC18 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | CAMK2B | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | RAB9B | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
mRNA | ZNF3 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ZNF611 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |